What is APOE4? A plain-language primer

If you just learned you carry APOE4, hold onto one fact before anything else: a risk factor is not a diagnosis. APOE4 is the strongest common gene linked to late-onset Alzheimer’s, so it deserves your attention. But it changes the odds, it does not decide your future. Plenty of carriers reach old age with sharp, healthy brains. Here is what the gene actually is, why it matters, and what you can do about it.

What APOE actually does

APOE stands for apolipoprotein E. It is a protein your body uses to package and move cholesterol and other fats around, both through your bloodstream and inside your brain. Think of it as the shipping system for lipids: it loads fats onto particles, delivers them to the cells that need them, and clears the leftovers.

The gene that codes for it comes in three common versions, called alleles:

• APOE2 is relatively protective, and the rarest.
• APOE3 is the most common and treated as neutral.
• APOE4 is the one tied to higher risk.

You inherit one copy from each parent, so everyone ends up with one of six pairs (3/3, 3/4, 4/4, and so on, walked through in the genotypes explained). About 15% to 25% of people carry at least one copy of APOE4, and roughly 2% to 3% carry two. The exact figures shift with ancestry.

Why a lipid gene affects the brain

This is the part that makes APOE4 click. Your brain is an extraordinarily fatty organ, roughly 60% fat by dry weight, and it has to build and maintain itself out of cholesterol and lipids. It mostly makes its own, because the blood-brain barrier blocks the supply coming from your bloodstream, so it leans heavily on APOE to move those lipids from cell to cell.

The ε4 version is simply worse at the job. It binds to its receptors and to lipids less efficiently than the common ε3 version, and those small handling problems ripple into the exact processes that go wrong in Alzheimer’s. ε4 is worse at clearing amyloid-beta, the sticky protein fragment that clumps into the plaques seen in the disease. It tips the brain’s resident immune cells toward more inflammation. And it is linked to an earlier breakdown of the blood-brain barrier, the tight seal that keeps the wrong things out of brain tissue. None of these is an on-off switch. They are nudges that, over decades, can add up. That same lipid-handling machinery also affects your arteries, which is why APOE4 touches both the brain and the heart. We go deeper in how APOE4 affects the brain.

Why APOE4 matters: the numbers

APOE4 is the strongest common genetic risk factor for late-onset Alzheimer’s, the form that usually shows up after age 65. The risk numbers only mean something once you anchor them to a baseline, so start here: someone with the common 3/3 genotype has roughly a 10 to 15% lifetime risk of Alzheimer’s dementia by age 85. Each copy of ε4 raises it from there.

Genotype	Relative risk vs 3/3	Approx. lifetime risk by 85
3/3 (no copies)	reference (1x)	~10 to 15%
3/4 (one copy)	~3 to 4x	~20 to 30%
4/4 (two copies)	~9 to 15x	~30 to 60%

The relative-risk figures come from the large Farrer meta-analysis. The absolute ranges are wide because they shift with age, sex, and ancestry. Read the relative and absolute columns together: a 4/4 carrier’s risk is many times higher in relative terms, but even at the high end of the absolute range, it is not a certainty.

Two copies keep looking more serious the closer researchers look. A 2024 study found that more than 95% of 4/4 carriers already show Alzheimer’s biomarkers by age 55, with most developing symptoms by their mid-60s. The authors argued that 4/4 behaves less like a risk factor and more like a distinct genetic form of the disease. Two copies also tends to pull the average age of onset earlier, often by a decade or more compared with non-carriers.

One thing the averages hide: sex matters. A woman with one copy may carry risk closer to a man with two, especially across the menopause transition (see women and sex differences).

These are population averages, not personal guarantees. Many APOE4 carriers live long lives with healthy brains, and many people who develop Alzheimer’s carry no ε4 at all. For the fuller picture of what these figures do and do not say, see does APOE4 shorten your life.

What APOE4 does not mean

• It is not deterministic. APOE4 is one factor among many. Age, sex, lifestyle, cardiovascular health, and other genes all weigh in.
• It is not a diagnosis. It does not mean you have Alzheimer’s, and it does not mean you will get it.
• It does not make lifestyle pointless. The opposite, in fact: the evidence suggests the modifiable levers may matter more for carriers, not less.

Common questions

If I carry APOE4, will I get Alzheimer’s? Not necessarily. Even with two copies, most cohort estimates put somewhere around 40 to 60% of 4/4 carriers reaching age 85 without Alzheimer’s dementia, and with one copy the odds of staying clear are better still. APOE4 raises the odds. It does not seal the outcome.

Can I find out if I carry it? Often yes, sometimes from consumer DNA data you already have. See how to get tested and the step-by-step find your APOE status in 23andMe.

Should my family be worried? APOE alleles run in families, so relatives may share the variant. The same “risk, not destiny” framing applies to them. See should your relatives get tested.

What to do next

The two outcomes most strongly tied to APOE4 are neurodegeneration (Alzheimer’s) and cardiovascular disease, and almost everything actionable flows from those two:

• Protect the brain: cognitive, vascular, and metabolic health.
• Protect the heart: lipids, blood pressure, and inflammation.

If this feels like a lot, the calm, step-by-step path in Start Here is the place to go next. The rest of this site digs into each lever with the same goal throughout: turning the science into clear steps you can actually take.

Remember: this is education, not medical advice. Your genotype is one piece of a much bigger picture that you and your doctor should interpret together.